Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Construction in Progress (2016 - 2024)

Utah Medical Products (UTMD) has 14 years of Construction in Progress data on record, last reported at $19000.0 in Q4 2024.

  • For Q4 2024, Construction in Progress fell 98.66% year-over-year to $19000.0; the TTM value through Dec 2024 reached $19000.0, down 98.66%, while the annual FY2024 figure was $19000.0, 98.66% down from the prior year.
  • Construction in Progress reached $19000.0 in Q4 2024 per UTMD's latest filing, down from $1.4 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $1.4 million in Q4 2023 and bottomed at $19000.0 in Q4 2024.
  • Average Construction in Progress over 5 years is $752600.0, with a median of $898000.0 recorded in 2021.
  • Peak YoY movement for Construction in Progress: skyrocketed 70.4% in 2021, then plummeted 98.66% in 2024.
  • A 5-year view of Construction in Progress shows it stood at $527000.0 in 2020, then surged by 70.4% to $898000.0 in 2021, then grew by 0.89% to $906000.0 in 2022, then skyrocketed by 55.96% to $1.4 million in 2023, then tumbled by 98.66% to $19000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Construction in Progress were $19000.0 in Q4 2024, $1.4 million in Q4 2023, and $906000.0 in Q4 2022.